256 related articles for article (PubMed ID: 35797441)
41. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
Soran A; Menekse E; Girgis M; DeGore L; Johnson R
Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
[TBL] [Abstract][Full Text] [Related]
43. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program.
Gandhi A; Xu T; DeSnyder SM; Smith GL; Lin R; Barcenas CH; Stauder MC; Hoffman KE; Strom EA; Ferguson S; Smith BD; Woodward WA; Perkins GH; Mitchell MP; Garner D; Goodman CR; Aldrich M; Travis M; Lilly S; Bedrosian I; Shaitelman SF
Breast; 2023 Apr; 68():205-215. PubMed ID: 36863241
[TBL] [Abstract][Full Text] [Related]
44. Loco-regional therapy and the risk of breast cancer-related lymphedema: a systematic review and meta-analysis.
Lin Y; Xu Y; Wang C; Song Y; Huang X; Zhang X; Cao X; Sun Q
Breast Cancer; 2021 Nov; 28(6):1261-1272. PubMed ID: 34106427
[TBL] [Abstract][Full Text] [Related]
45. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
[TBL] [Abstract][Full Text] [Related]
46. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
Wijaya WA; Peng J; He Y; Chen J; Cen Y
Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
[TBL] [Abstract][Full Text] [Related]
47. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
Shah C; Vicini FA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
[TBL] [Abstract][Full Text] [Related]
48. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL).
Liao SF; Li SH; Huang HY; Chen ST; Kuo SJ; Chen DR; Wei TS
Breast; 2013 Oct; 22(5):703-6. PubMed ID: 23321586
[TBL] [Abstract][Full Text] [Related]
49. A 10 Minute Self-Care Program May Reduce Breast Cancer-Related Lymphedema: A Six-Month Prospective Longitudinal Comparative Study.
Arinaga Y; Sato F; Piller N; Kakamu T; Kikuchi K; Ohtake T; Sakuyama A; Yotsumoto F; Hori T; Sato N
Lymphology; 2016 Jun; 49(2):93-106. PubMed ID: 29906367
[TBL] [Abstract][Full Text] [Related]
50. Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors.
Terada M; Yoshimura A; Sawaki M; Hattori M; Naomi G; Kotani H; Adachi Y; Iwase M; Kataoka A; Sugino K; Mori M; Horisawa N; Ozaki Y; Iwata H
Breast Cancer Res Treat; 2020 Jan; 179(1):91-100. PubMed ID: 31535321
[TBL] [Abstract][Full Text] [Related]
51. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
Iyigun ZE; Duymaz T; Ilgun AS; Alco G; Ordu C; Sarsenov D; Aydin AE; Celebi FE; Izci F; Eralp Y; Ozmen V
Lymphat Res Biol; 2018 Feb; 16(1):28-35. PubMed ID: 28346852
[TBL] [Abstract][Full Text] [Related]
52. Risk of Lymphedema Following Contemporary Treatment for Breast Cancer: An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective.
Byun HK; Chang JS; Im SH; Kirova YM; Arsene-Henry A; Choi SH; Cho YU; Park HS; Kim JY; Suh CO; Keum KC; Sohn JH; Kim GM; Lee IJ; Kim JW; Kim YB
Ann Surg; 2021 Jul; 274(1):170-178. PubMed ID: 31348041
[TBL] [Abstract][Full Text] [Related]
53. Lymphaticovenular Anastomosis in Breast Cancer Treatment-Related Lymphedema: A Short-Term Clinicopathological Analysis from Indonesia.
Brahma B; Putri RI; Reuwpassa JO; Tuti Y; Alifian MF; Sofyan RF; Iskandar I; Yamamoto T
J Reconstr Microsurg; 2021 Oct; 37(8):643-654. PubMed ID: 33648010
[TBL] [Abstract][Full Text] [Related]
54. Periclavicular Lymph Node Activation Maintains the Lymphatic Circulation of Upper Extremity Following Breast Cancer Surgery with Axillary Lymph Node Dissection.
Kang SH; Lee DG
Lymphat Res Biol; 2021 Jun; 19(3):256-260. PubMed ID: 32986507
[No Abstract] [Full Text] [Related]
55. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.
Cariati M; Bains SK; Grootendorst MR; Suyoi A; Peters AM; Mortimer P; Ellis P; Harries M; Van Hemelrijck M; Purushotham AD
Br J Surg; 2015 Aug; 102(9):1071-8. PubMed ID: 26040263
[TBL] [Abstract][Full Text] [Related]
56. Current Diagnostic Tools for Breast Cancer-Related Lymphedema.
Shah C; Asha W; Vicini F
Curr Oncol Rep; 2023 Mar; 25(3):151-154. PubMed ID: 36696076
[TBL] [Abstract][Full Text] [Related]
57. Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level.
Yuan Q; Hou J; He Y; Liao Y; Zheng L; Wu G
BMC Cancer; 2021 Mar; 21(1):293. PubMed ID: 33740930
[TBL] [Abstract][Full Text] [Related]
58. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
[TBL] [Abstract][Full Text] [Related]
59. A Prospective Study of L-Dex Values in Breast Cancer Patients Pretreatment and Through 12 Months Postoperatively.
Ridner SH; Dietrich MS; Spotanski K; Doersam JK; Cowher MS; Taback B; McLaughlin S; Ajkay N; Boyages J; Koelmeyer L; DeSnyder S; Shah C; Vicini F
Lymphat Res Biol; 2018 Oct; 16(5):435-441. PubMed ID: 30130147
[TBL] [Abstract][Full Text] [Related]
60. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema.
Sun F; Skolny MN; Swaroop MN; Rawal B; Catalano PJ; Brunelle CL; Miller CL; Taghian AG
Breast Cancer Res Treat; 2016 Jun; 157(2):229-240. PubMed ID: 27154787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
